Kev tswj cov kab mob metabolic tau hloov pauv ntau xyoo dhau los. Lub ntiaj teb kev rog rog yog siab dua 650 lab, thiab ntshav qab zib hom 2 yog kis thoob qhov txhia chaw. Cov kws kho mob tsis tu ncua nrhiav kev kho mob zoo rau cov mob no. Cov tshuaj niaj hnub uas tsom ib yam khoom muaj txiaj ntsig, tab sis cov kab mob metabolic yog qhov sib txawv thiab sib cuam tshuam uas lawv feem ntau xav tau ntau yam kev kho mob.Tom ntej: Bioglutide NA-931, ib lub qhov ncauj me me molecule tshuaj, revolutionises metabolic tswj nrog nws quadruple receptor activation txheej txheem.
Bioglutide NA-931 lub hom phiaj rau plaub lub receptor systems ib txhij, tsis zoo li lwm yam tshuaj. Qhov no muaj GCGR, GLP-1R, GIPR, thiab IGF-1R. Txhawm rau kom poob phaus, tswj cov piam thaj homeostasis, thiab tsim cov nqaij ntshiv, qhov no multimodal mus kom ze ua rau hormonal tshuav. Qhov ncauj bioavailability cais nws los ntawm kev txhaj tshuaj peptides. Cov phiaj xwm kho mob yooj yim dua rau cov neeg mob ua raws. Yuav kom nkag siab txog yuav ua li cas Bioglutide NA-931 tswj cov txheej txheem metabolic, peb yuav tsum kawm nws txoj kev sib koom tes sib txuas thiab lub zog ntsuas ntsuas. Cov tshuaj tshiab thiab complex molecular circuit txhim khu kev noj qab haus huv metabolic thoob plaws ntau lub cev hauv kev tshawb fawb no.
Tom ntej: Bioglutide NA-931
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
(3) Capsules
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Internal Code: KP-2-6/002
Tom ntej: Bioglutide NA-931
Chaw tsim tshuaj paus: BLOOM TECH Wuxi Hoobkas
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Kev them nyiaj yug Technology: R&D Dept.-4
Peb muab Bioglutide NA-931, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov khoom lag luam.
Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html
Dab tsi yog Multi-Lub Hom Phiaj Mechanism Qab Bioglutide NA-931?
Bioglutide NA-931 lub peev xwm ua rau tib lub sijhawm qhib plaub txoj hauv kev metabolically tseem ceeb receptor ua rau nws txoj kev kho mob zoo. Lub tswv yim plaub agonist no txawv ntawm kaum xyoo ntawm kev txo qis ib leeg - phiaj xwm kev txhim kho tshuaj. Tib neeg cov kab mob metabolic muaj kev sib cuam tshuam thiab kev tawm tswv yim loops. Cov tshuaj ib hom phiaj feem ntau tsis nco txog qhov tseeb lom neeg.
Traditional tshuaj metabolic cuam tshuam rau ib qho receptor. Qhov no yuav pib muaj cov txiaj ntsig tseem ceeb, tab sis feem ntau nws txo qis kev siv tshuaj. Ib leeg GLP-1 receptor agonists zoo li semaglutide tuaj yeem pab tib neeg kom poob phaus thiab sib npaug ntawm lawv cov ntshav qab zib, tab sis lawv tuaj yeem ua rau cov leeg tsis muaj zog thiab mob plab hnyuv uas ua rau cov neeg mob tsis tshua ua raws li lawv cov phiaj xwm kho mob. Kev kho mob mus sij hawm ntev yuav ua tsis tiav vim lub cev lub cev homeostatic sib npaug cov haujlwm tshwj xeeb no.
Bioglutide NA-931's multi-receptor method boosts compensatory reactions es tsis sib tw nrog lawv. Ua kom GLP-1R txo kev tshaib kev nqhis thiab nce insulin. GIPR activation boosts thermogenesis thiab rog metabolism. Txhim kho IGF-1R tswj cov leeg nqaij ntshiv poob thaum lub sijhawm txwv calorie thaum ua kom GCGR txhawb cov metabolism. Cov qauv kev sib koom ua ke no ua rau muaj qhov chaw metabolic uas pab tib neeg kom poob phaus thiab ua kom tsis txhob poob cov leeg zoo li thaum lawv txiav calories sai heev.
Ntau- lub hom phiaj kws tshuaj yog ua raws li kev ua lej hauv qhov chaw uas muaj kev sib koom ua ke tuaj yeem cuam tshuam cov teebmeem ntxiv ntawm txhua txoj hauv kev. Bioglutide NA-931 boosts ib -txoj kev impulses ntawm receptor crosstalk. GLP-1R nce cAMP, uas pab GIPR tso tawm adiponectin. Cov tshuaj hormone no nce insulin thiab rog rog. Tsis tas li ntawd, GCGR-activated AMPK txhim kho qhov anabolic mTORC1 kev taw qhia txoj hauv qab ntawm IGF-1R. Qhov no boosts nqaij protein synthesis nyob rau hauv lub xeev uas tsis muaj zog.
Qhov kev sib koom ua ke ntawm receptor no siv cov ntaub so ntswg- cov qauv kev faib tawm tshwj xeeb los ua kom cov lus teb kho tau thiab txo cov kev mob tshwm sim. Vim tias nws cov ntsiab lus GCGR siab, lub siab ua haujlwm zoo dua rau cov lus qhia ntawm cov piam thaj thiab rog. Beta cells qhib GLP-1R thiab GIPR kom tso cov tshuaj insulin raws li qhov xav tau. Cov leeg pob txha muaj ntau IGF-1R, yog li kev tiv thaiv anabolic signals ncav cuag cov ntaub so ntswg uas nkag siab zoo rau catabolic kev ntxhov siab thaum poob phaus. Qhov no spatial receptor activation qauv ua rau cov tshuaj ua haujlwm tshwj xeeb txawm hais txog ntau lub hom phiaj.
Nws cov qauv me me molecule rendersTom ntej: Bioglutide NA-931siv tau thaum noj los ntawm qhov ncauj, tsis zoo li peptide-raws li GLP-1 agonists, uas xav tau kev hloov kho tshuaj lom neeg. Nws kuj ua haujlwm nrog ntau tus receptors. Tej zaum nws yuav tau noj ib zaug ib hnub txij li nws cov tshuaj lom neeg tso cai rau lub plab zom mov thiab lub siab ua ntej - dhau txoj sia. Txoj kev no tshem tawm cov teeb meem nrog kev txhaj tshuaj, uas ua rau cov kev kho mob metabolic tam sim no nyuaj rau qee tus neeg, tshwj xeeb yog cov neeg uas ntshai koob lossis xav tau kev kho mob ntev. Kev tshawb fawb soj ntsuam pom tau hais tias qhov ncauj koob tshuaj stabilizes plasma concentrations thiab pharmacokinetics. Qhov no qhia tau hais tias receptors tau qhib thaum noj.
Receptor Signaling Networks Activated los ntawm Bioglutide NA-931
Thaum bioglutide NA-931 khi rau nws plaub lub hom phiaj receptors, cov teeb liab nyuaj pib hauv hlwb, txhawb kev kho. Txhua receptor coupling pib biochemical txoj hauv kev uas ua rau tib lub hom phiaj metabolic. Qhov no ua kom lub cev muaj zog cov lus teb los ntawm kev rov ua dua.
GLP-1R Txoj Kev: Central thiab Peripheral Metabolic Control
Bioglutide NA-931 activates GLP-1 receptors, cuam tshuam CNS thiab metabolism. Pro-opiomelanocortin (POMC) neurones nyob rau hauv pituitary arcuate nucleus tsim alpha-melanocyte-stimulating hormone tom qab GLP-1R ua kom. Neuropeptide Y thiab agouti ntsig txog peptide neurones, uas ua rau koj tshaib plab, raug thaiv los ntawm cov neuropeptide no, uas txhawb nqa melanocortin-4 receptor Calories noj tsawg tsawg yam tsis muaj kev txhawj xeeb txog kev puas hlwb pom nrog lwm yam qab los noj mov.
Thaum cov piam thaj ntau ntau, beta hlwb qhib GLP-1R kom tso cov tshuaj insulin ntau dua. Nws tso siab rau cov ntshav qabzib. Qee cov tshuaj ntshav qab zib tuaj yeem tsim cov tshuaj hypoglycemia, txawm hais tias cov piam thaj dependence zam nws. Tus receptor nce intracellular cAMP. Nws ua rau cov tshuaj insulin- secreting system rhiab heev rau cov kua nplaum uas ua rau calcium nce. Alpha cells inhibit glucagon tso tawm ntawm GLP-1R. Tsis tas li ntawd txo qis hepatic glucose synthesis txhim kho cov ntshav qab zib tswj. Bioglutide NA-931 txo qis hemoglobin A1c hauv kev tshawb fawb soj ntsuam, txhawb nqa cov txiaj ntsig ntawm pancreatic.
GIPR Kev Koom Tes: Kev kho cov ntaub so ntswg adipose thiab metabolic Efficiency
Gastric inhibitory peptide receptors txhim kho cov metabolism ntxiv rau GLP-1R. GIPR ua kom cov rog dawb nce adiponectin ntau lawm. Qhov no adipokine boosts lub siab thiab cov leeg nqaij insulin rhiab heev thiab rog hlawv. Cov rog hauv daim siab thiab cov leeg ua rau cov tshuaj insulin tsis kam, yog li lawv poob rog. Brown adipose cov ntaub so ntswg tsim uncoupling protein-1 ntawm GIPR. Thaum tshav kub kub los ntawm chemical zog nce physiological zog siv.
Active GIPR thiab GLP-1R hauv pancreatic islets nce insulin tso tawm ntau dua li txoj kev ib leeg. Qhov kev sib xyaw ua ke no txo cov neeg txais neeg nyob, uas muaj cov txiaj ntsig kho mob thiab tsawg dua cov kev mob tshwm sim ntau dua li qhov siab tshaj plaws ib leeg - receptor activation. Tom qab noj mov, Bioglutide NA-931 txo cov piam thaj hauv ntshav los ntawm 37% piv rau cov placebo hauv theem II kuaj. Cov nyhuv incretin yog qhov tseem ceeb. Txoj hauv kev GIPR tiv thaiv beta cell tuag thiab nce cell loj hlob, uas tuaj yeem tswj cov islet muaj nuj nqi txawm tias kev kho mob mus ntev.
GCGR Ua kom muaj zog: Kev Sib Txuas Zog Tsis Muaj Cov leeg nqaij Catabolism
Glucagon receptor activation tsub kom cov piam thaj hauv siab ntau lawm thiab fatty acid hlawv thaum yoo mov, muab lub zog. Lub hepatocyte cAMP-PKA- txoj kev CREB tau qhib los ntawm GCGR thiab NA-931. Qhov no nce gluconeogenesis thiab ketogenesis. Qhov kev hloov metabolic no hlawv rog ntau dua thiab lub zog. Cov kev tshawb fawb soj ntsuam pom tau tias Bioglutide NA-931 boosts basal metabolic tus nqi 12-15%. Nws cuam tshuam rau qhov sib txawv calorie uas xav tau kom poob phaus.
Active GCGR tuaj yeem ua rau cov leeg nqaij muaj protein ntau rau gluconeogenesis. IGF-1R activation los ntawm bioglutide NA-931 khaws cov ntaub so ntswg thiab tiv thaiv degradation. Lub sij hawm ntev tswj qhov hnyav thiab kev noj qab haus huv metabolic yog txhim kho los ntawm kev tuav cov leeg nqaij thaum poob phaus. Hauv kev sim, bioglutide NA-931 tswj lub cev hnyav rau 12 lub lis piam. Tsis zoo li lwm cov kev tswj hwm '3-4% cov leeg poob.
IGF-1R Stimulation: Kev Tiv Thaiv Anabolic thiab Metabolic Flexibility
Insulin-zoo li kev loj hlob zoo-1 receptor activation balances cov tshuaj hormones rau kev poob phaus. PI3K-Akt-mTOR leeg nqaij protein synthesis yog nrawm los ntawm IGF-1R. Cov teeb liab los ntawm qhov cascade no txhim kho ribosome txhais lus ntawm tus tub txib RNA thiab inhibit ubiquitin-proteasome protein degradation. Txawm hais tias catabolic kev ntxhov siab los ntawm kev txwv calorie thiab lwm yam receptor mechanisms, cov leeg nqaij protein sib npaug yog khaws cia.
Efficiency leap Precision thiab stability
Kev siv siab -kev ua tau zoo sib koom ua ke, CRA series tuaj yeem ua rau lub sijhawm nce los ntawm 25%, thiab cov khoom lag luam tuaj yeem ncav cuag lub ncov tshiab; kev vibration suppression algorithm tau hloov kho kom ua tiav qhov zoo los tiv thaiv - co nyhuv; tag nrho - parameter DH them nyiaj algorithm thiab TrueMotion algorithm yog kev txhawb nqa 2. 0.4 hli nyob rau hauv qhov kev hloov ntawm tus cwj pwm txav, thiab cov lus nkhaus yog qhov tseeb thiab ruaj khov.
Bioglutide NA-931 Ua li cas tswj kev noj qab haus huv, piam thaj, thiab kev tswj lub zog?
Tom ntej: Bioglutide NA-931tswj hwm ntau lub tshuab receptor los tsim cov lus teb metabolic uas tswj kev tshaib plab, tswj cov qib qabzib, thiab tswj lub zog sib npaug. Tshawb nrhiav seb cov kab ke no cuam tshuam li cas qhia tau tias kev kho mob zoo nkauj npaum li cas.
Hypothalamic Integration ntawm Satiety Signals
Hypothalamic nuclei tswj kev tshaib kev nqhis. Hormonal signals thiab neuronal inputs ntawm zaub mov zoo yog kev koom ua ke los ntawm cov nuclei. GLP-1R agonism los ntawm bioglutide NA-931 stimulates arcuate nucleus POMC neurones. Ntau GLP-1 receptors nyob rau hauv cov neurones. Neurones qhia kev pub noj-tswj paraventricular nuclei. Melanocortin peptides qhib MC4 receptors. Ib qho ntawm lub cev zoo tshaj plaws kev tshaib kev nqhis-tswj mechanisms.
Kev puv puv hloov li cas koj lub hlwb txhais cov khoom plig khoom plig thiab txo kev tshaib kev nqhis. Cov kev tshawb fawb pom kev ua haujlwm siv GLP-1 receptor agonists qhia tias cov duab noj mov zoo txo qis mesolimbic nqi zog hauv Circuit Court. Hedonic noj- noj kom txaus siab es tsis tsim nyog-poob nrog lub hlwb teb hloov pauv. Bioglutide NA-931 txo qhov xav tau zaub mov thiab txhim kho kev noj zaub mov zoo. Calorie noj poob 20-25% los ntawm lub hauv paus, sib piv cov lus tshaj tawm tau txais.
Kev sib koom ua ke ntawm Pancreatic Insulin thiab Glucagon Secretion
Pancreatic islets yuav tsum tso cov tshuaj insulin thiab glucagon ib txhij los tswj cov piam thaj. Beta hlwb pab lub cev nqus cov piam thaj thaum noj, thaum alpha hlwb tso glucagon ntawm pluas noj. Hom 2 mob ntshav qab zib mellitus yog tshwm sim los ntawm ntau glucagon thiab insulin tsis txaus. Bioglutide NA-931 modulates islet hormone receptors. Los ntawm GLP-1R thiab GIPR, qabzib nce beta cell insulin tso tawm. Kev noj cov piam thaj ua rau cov nyhuv incretin. Cov txheej txheem no tiv thaiv cov ntshav qab zib tsawg vim nws tsuas yog ua haujlwm thaum cov ntshav qab zib nce ntxiv. GLP-1R activation nyob rau hauv alpha hlwb suppresses glucagon tso tawm.
Txo cov piam thaj hauv siab ua rau cov ntshav qabzib sai sai. Hauv kev sim tshuaj, kev yoo mov qabzib txo qis 30-40 mg / dL thiab cov ntshav qab zib tau tswj tau zoo dua tom qab noj mov. Qhov tseem ceeb, kev txo qis cov piam thaj tsis ua rau muaj kev pheej hmoo hypoglycemia. Cov piam thaj ib txwm txo qis cov tshuaj insulin vim tias incretins tswj nws. Kev tswj lub cev no txawv ntawm qabzib- txo sulfonylurea thiab insulin. Bioglutide NA-931 ua rau cov placebo zoo li hypoglycemia hauv theem II kev sim. Qhov xav tau kev nyab xeeb profile raws li kev ua haujlwm tau lees paub.
Hepatic thiab Adipose Tissue Energy Flux Management
Ntev -Lub sij hawm tswj qhov hnyav yuav tsum tau synchronizing daim siab thiab roj cell metabolism, uas khaws thiab siv feem ntau ntawm peb lub zog. GCGR txhawb nqa los ntawm bioglutide NA-931 hlawv rog thiab tsim cov ketones. Qhov no siv triglycerides rau lub zog. GLP-1R thiab GIPR nce siab insulin rhiab heev, txo cov insulin tsis kam thiab tsim rog. Qhov kev ua ob txoj kev txo cov rog hauv siab, raws li kev sib nqus resonance imaging qhia 28% qis siab triglycerides.
Cov ntaub so ntswg hloov pauv nrog bioglutide NA-931. Adipocyte inflammatory cytokines txo qis thiab adiponectin ntau lawm nce nrog GIPR kev cuam tshuam. Qhov kev hloov pauv no los ntawm inflammatory mus rau metabolically noj qab nyob zoo cov ntaub so ntswg adipose nce insulin rhiab heev thiab txo cov kab mob plawv. GIPR-mediated thermogenesis nce kev siv zog hauv cov ntaub so ntswg adipose. Hauv kev tshawb nrhiav cov khoom noj khoom haus, cov neeg kho tau siv oxygen ntau dua thiab tsim kom muaj cua sov ntau dua.
Cov teebmeem ntawm daim siab thiab cov roj ntsha no cuam tshuam cov kev hloov pauv hormonal uas ua rau qhov hnyav txo qis. Koj cov metabolism yuav txo qis thaum koj poob phaus. Siv lub zog tsawg dua nws rov qab. Bioglutide NA-931's thermogenic thiab metabolic rate-boosting properties inhibit adaption, yog li kev siv hluav taws xob nyob twj ywm txawm tias poob ntau. Qhov no tuaj yeem piav qhia vim li cas qhov hnyav poob qis dua 6- mus rau 12-hli toj siab ntawm kev kho mob feem ntau.
Metabolic Pathway Interactions Tsav los ntawm Bioglutide NA-931
Bioglutide NA-931 pib cell-molecule kev sib cuam tshuam dhau ntawm receptor signals. Cov kev sib cuam tshuam no suav nrog kev sib koom ua ke metabolic network thiab kev tawm tswv yim. Cov kab ke no- theem cuam tshuam sib txawv ntau lub hom phiaj agonists los ntawm kev sib xyaw tshuaj tshuaj uas ntaus ib lub hom phiaj.
Cyclic AMP yog GCGR, GLP-1R, thiab GIPR tus xa xov thib ob, yog li lawv tuaj yeem ua rau ib leeg cov cim.Tom ntej: Bioglutide NA-931elevates cAMP qib siab dua ib qho receptors thaum nws cuam tshuam ntau Gs -coupled receptors. Lub zog cAMP signaling activates protein kinase A, uas cuam tshuam cov metabolism, gene synthesis, thiab cell ua hauj lwm ntau dua.
Qhov cuam tshuam ntawm kev nce siab cAMP ntawm ntau cov ntaub so ntswg nyob ntawm lawv cov PKA substrates thiab cov nyhuv downstream. PKA phosphorylates hormone-sensitive lipase thiab perilipin proteins hauv adipocytes, ua rau triglyceride thauj yooj yim dua. Kev ua kom PKA ua rau pancreatic beta hlwb 'insulin- zais cov tshuab ua haujlwm ntau dua rau cov teeb liab calcium. Hepatocytes phosphorylate CREB ntawm PKA kom nce gluconeogenic thiab ketogenic enzymes. Txawm hais tias cov pab pawg neeg sib txawv xa cov teeb liab, pleiotropic cAMP signaling tswj cov lus teb metabolic hla cov ntaub so ntswg.
Thaum lub cell lub zog qis qis, AMP-activated protein kinase activates catabolic pathways thiab inhibits anabolic sawv daws yuav. Bioglutide NA-931 activates GCGR, uas nce cell AMP rau ATP thiab coj cov dej ntws mus rau kinase activation ntawm AMPK. AMPK activation nce qabzib nqus, inhibits lipogenesis, thiab txhawb cov fatty acid oxidation. Cov teebmeem no ntxiv rau cov khoom siv roj ntsha.
Qhov tseem ceeb, ua kom AMPK nce PGC-1alpha, uas txhawb nqa cov metabolism hauv aerobic. Qhov kev hloov pauv no pab cov hlwb siv GCGR thiab GIPR-tso fatty acids zoo dua, tiv thaiv lipotoxicity los ntawm ntau lipids. Cov nqaij leeg tau txais txiaj ntsig los ntawm kev nthuav dav mitochondrial vim tias nws ua rau cov metabolism hloov pauv tau yooj yim thiab cov tshuaj insulin rhiab heev. Cov kev hloov kho no piav qhia txog vim li cas Bioglutide NA-931 txoj kev kho mob ncua sijhawm metabolic.
Lub hom phiaj mammalian ntawm rapamycin txoj kev sib txuas lub zog, kev loj hlob zoo, thiab kev noj zaub mov zoo. Txoj kev no tswj kev loj hlob ntawm tes thiab kev tsim cov protein. Bioglutide NA-931 txhawb nqa IGF-1R, uas ua rau mTORC1 ntawm PI3K-Akt. Cov nqaij protein synthesis nce. Txawm hais tias muaj kev txwv caloric thiab GCGR-mediated zog siv ua catabolic, qhov teeb meem anabolic no tshwm sim.
AMPK feem ntau inhibits mTORC1 thaum lub cev muaj zog, yog li AMPK thiab mTOR yuav tsis ua haujlwm ua ke. Txawm li cas los xij, cov ntsuas no hloov mus rau lub sijhawm thiab qhov chaw, ua rau ob txoj hauv kev siv tau. IGF-1R signaling nyob rau hauv cov nqaij ntshiv txhawb mTORC1, uas hla AMPK qhov inhibiting ua thiab tswj cov leeg nqaij protein synthesis. Txawm li cas los xij, daim siab thiab cov ntaub so ntswg adipose AMPK ua kom nrawm catabolism yam tsis muaj kev ua haujlwm mTOR. Cov ntaub so ntswg no- hom- tshwj xeeb teeb liab compartmentalisation qhia tau li cas Bioglutide NA-931's multi-target design tswj cov metabolism nyuaj.
Mob ntshav qab zib thiab rog rog yog txuas mus rau qhov tsis tshua muaj - qib o, uas ua rau cov tshuaj insulin tsis kam thiab kev pheej hmoo mob plawv. Pro-inflammatory cytokines thiab macrophages hauv cov ntaub so ntswg adipose tsim cov tshuaj insulin-insensitive metabolic xeev uas khaws cov rog. Bioglutide NA-931 hais txog qhov mob ntawm ntau txoj hauv kev.
Cov ntaub so ntswg adipose tsim cov tshuaj tiv thaiv -inflammatory adiponectin es tsis txhob TNF-alpha thiab IL-6 thaum GIPR tshwm sim. Los ntawm kev txo qis NF-kappaB kev ua thiab inflammatory gene qhia, GLP-1R ncaj qha txo qhov mob ntawm ntau yam kabmob. Tib neeg biomarker kuaj pom tias Bioglutide NA-931 txo C-reactive protein thiab lwm yam inflammatory indicators. Cov kev hloov kho no txhim kho cov tshuaj insulin rhiab heev thiab txo cov kab mob plawv. Cov tshuaj tiv thaiv kab mob yog ib qho ntawm cov tshuaj lom neeg muaj txiaj ntsig tshaj qhov poob phaus.
Kev Tshawb Fawb Txog Kev Tshawb Fawb Txog Kev Loj Hlob Metabolic ntawm Bioglutide NA-931
Cov kws tshawb fawb tam sim no nkag siab li cas Bioglutide NA-931 cuam tshuam ntau txoj hauv kev metabolic. Bioglutide NA-931, ib qho tshuaj nyuaj, tau pom tias muaj kev nyab xeeb, ua tau zoo, thiab tau txais txiaj ntsig zoo hauv ntau pawg neeg mob hauv theem I thiab II kev sim tshuaj. Cov kev tshawb fawb no txhawb nqa ntau lub hom phiaj receptor agonism qhov zoo.
Cov neeg koom nrog hauv kev tshawb fawb theem II muaj BMI ntawm 30 kg / m² lossis ntau dua, lossis hnyav dua thiab muaj teeb meem kev noj qab haus huv ntxiv. Kev kho cov neeg no yog lub hom phiaj. Kev hloov pauv qhov hnyav thaum pib thiab hemoglobin A1c thiab kev tswj ntshav qabzib yog lub hom phiaj tseem ceeb. Tom qab 24 lub lis piam, cov tshuaj Bioglutide NA-931 siab tshaj plaws tau txo qis 12-15% ntawm lawv lub cev hnyav. Qhov no ua tau zoo dua cov pab pawg placebo thiab tau muab piv rau lwm txoj hauv kev tswj qhov hnyav.
Kev txhim kho glycemic kuj tseem muaj txiaj ntsig zoo hauv cov neeg mob ntshav qab zib.
Ntau tus neeg uas muaj qib hemoglobin A1c qis tau hloov pauv los ntawm ntshav qab zib mus rau cov ntshav qab zib los yog ib txwm muaj. Tom qab- pluas mov qabzib txo qis tsawg dua li cov piam thaj sai sai ntawm 35–45 mg / dL. Qhov hnyav txo thiab txhim kho cov piam thaj tau tsim cov kev hloov pauv hauv metabolic uas ua haujlwm zoo ua ke. Interestingly, tsis yog - mob ntshav qab zib mellitus tau nthuav tawm cov kev hloov pauv ntawm cov piam thaj hauv cov ntshav. Qhov no qhia tau hais tias cov txheej txheem tuaj yeem tiv thaiv cov neeg mob ntshav qab zib kom dhau los ua ntshav qab zib.
Dual-zog X-ray absorptiometry scans thaum pib thiab xaus ntawm qhov kev sim qhia tiasTom ntej: Bioglutide NA-931Feem ntau txo cov rog rog thaum tswj lossis nce lean lub cev loj. Cov duab ntawm lub cev no txawv ntawm cov tib neeg feem ntau poob phaus, uas yog 20-30% cov ntaub so ntswg ntshiv. IGF-1R-mediated anabolic signaling zam kev txo cov calories catabolic qhov tshwm sim thiab ua kom muaj zog ntxiv, ua kom cov leeg noj qab haus huv.
Kev khaws cov nqaij yog qhov tseem ceeb rau kev tswj qhov hnyav thiab cov metabolism. Lean cov ntaub so ntswg drives so metabolism. Poob cov leeg thaum noj zaub mov txo qis kev siv zog, ua rau hnyav nce. Bioglutide NA-931 tswj cov leeg nqaij kom tswj tau qhov metabolic raws li qhov hnyav poob. Lub zog thiab kev ua haujlwm muaj peev xwm tswj tau zoo ib yam lossis txhim kho thoob plaws hauv kev kho mob, qhia tias cov nqaij pob txha khaws cia tau ua haujlwm tau zoo. Txoj haujlwm no daws qhov teeb meem loj nrog kev siv tshuaj raws li qhov hnyav txo.
Metabolic biomarkers thiab cov kab mob plawv muaj feem cuam tshuam uas qhia tias ntev -kev noj qab haus huv yog lub hom phiaj thib ob. Cov ntshav siab systolic poob qis yog 8-12 mmHg, uas txo cov kab mob plawv. Lipids kho tau zoo heev. Triglycerides poob 25-30% thiab HDL cholesterol nce 8-12%. LDL cov roj cholesterol hloov pauv, txawm tias tsis yog -HDL cholesterol, qhov kev pheej hmoo siab dua, tseem nyob ruaj khov.
Siab -rhiab heev C-reactive protein poob qis, qhia tias muaj roj- cuam tshuam txog kev mob o mus ntev. Kev hloov pauv adiponectin thiab leptin qhia txog kev txhim kho cov nqaijrog metabolic. ALT thiab AST rov qab mus rau qhov qub nyob rau hauv cov neeg mob uas muaj qhov tseem ceeb dua qub, qhia tias tsis yog - haus dej cawv fatty siab kab mob tau daws. Cov kev txhim kho no qhia tau hais tias Bioglutide NA-931 txhim kho kev noj qab haus huv hauv ntau txoj hauv kev tshaj qhov poob phaus.
Kev soj ntsuam kev nyab xeeb thaum kev sim tshuaj ntsuam xyuas pom tias feem ntau tshwm sim nyob nruab nrab thiab luv luv. Cov tshuaj ua rau xeev siab thiab raws plab hauv 7-8% ntawm cov neeg siv. Qhov no yog qhov qis dua li qhov tshwm sim ntawm 30-40% nrog ntau npaum li cas ntawm GLP-1 receptor agents. Nws zoo nkaus li tias kev ua siab ntev tau tsim txij li feem ntau cov teeb meem plab tau daws yam tsis tau txiav tshuaj ntxiv li ntawm ob mus rau peb lub lis piam.
Hypoglycemia zoo ib yam li cov placebo, qhia tias Bioglutide NA-931's insulin tso tawm tso siab rau cov piam thaj. Hauv ob pab pawg kho mob, tsis muaj qhov xwm txheej hypoglycemia hnyav yuav tsum tau pab thib peb -. Cov teeb meem plawv tsis zoo dua piv rau cov placebo, thiab kev saib xyuas nquag tau nce. Theem III qhov kev sim siab yog ntsuas qhov ntev -lub sij hawm kev nyab xeeb los ntsuam xyuas seb qhov profile kev nyab xeeb zoo uas tau tshaj tawm hauv cov kev tshawb fawb luv luv yuav nyob li cas.
Xaus
Tom ntej: Bioglutide NA-931Lub hom phiaj ntawm plaub lub tshuab receptor los tswj kev qab los noj mov, cov piam thaj sib npaug, kev siv hluav taws xob, thiab lub cev muaj pes tsawg leeg, ua rau nws muaj kev kho mob metabolic ntse. Kev sib xyaw nrog ntau lub hom phiaj muaj kev sib koom ua ke ntau dua li ib qho - txoj kev kho mob. Nws qhov ncauj bioavailability yeej txhaj tshuaj. Kev sim tshuaj ntsuam xyuas qhia tias nws pab cov neeg mob poob phaus thiab tswj cov ntshav qab zib, thiab nws muaj kev nyab xeeb rau ntau tus neeg.
Cov dej num molecular ntawm bioglutide NA-931 qhia tias txoj hauv kev metabolic uas tshwm sim ua haujlwm sib txawv tuaj yeem sib koom ua ke. Tom qab txhim kho metabolic efficiency, inflammatory fatty cov ntaub so ntswg ploj zuj zus thiab lub siab thauj lub zog thaum sparing cov leeg vim txo kev tshaib kev nqhis thiab insulin rhiab heev. Qhov no metabolic reorganization ntawm cov kab ke zoo nkag siab txog kev rog thiab hom 2 mob ntshav qab zib 'kev nyuaj aetiology dua li tshuaj.
Bioglutide NA-931 tuaj yeem ua rau cov kab mob metabolic tshiab kho raws li theem III kev tshawb fawb thiab kev kho mob txuas ntxiv mus.
Kev sib xyaw ua ke qhia tias tsim kom muaj ntau lub hom phiaj hauv kev kho mob tuaj yeem ua haujlwm nrog cov txheej txheem nyuaj ntawm lub cev es tsis yog tawm tsam lawv, ua rau muaj txiaj ntsig kho mob yam tsis muaj kev hloov pauv ib zaug. Kev tshawb fawb tshuaj rau cov teeb meem mob ntev tau nce siab heev.
FAQ
Q1: Bioglutide NA -931 txawv li cas ntawm ib lub hom phiaj GLP-1 receptor agonists zoo li semaglutide?
Q2: Cov ntaub ntawv pov thawj dab tsi txhawb nqa cov leeg tuav pov hwm thaum poob phaus nrog Bioglutide NA-931?
Q3: Puas yog Bioglutide NA-931 haum rau cov neeg mob uas tsis muaj ntshav qab zib uas xav tswj lawv qhov hnyav?
Koom Tes Nrog BLOOM TECH: Koj Trusted Bioglutide NA-931 Tus neeg muab khoom rau Advanced Metabolic Research
Yog koj xav tauTom ntej: Bioglutide NA-931rau kev kawm, kev loj hlob, los yog lub hom phiaj kev lag luam, xaiv qhov zoo yog qhov tseem ceeb rau txoj haujlwm ua tiav. Shaanxi BLOOM Tech Co., Ltd. yog tus tsim nyog Bioglutide NA-931 tus neeg muag khoom nrog ntau tshaj 12 xyoos ntawm kev txawj ntse hauv cov tshuaj organic synthesis thiab tshuaj intermediates. Peb 100,000-square-meter GMP-certified chaw tsim khoom ua tau raws li cov qauv ntawm US FDA, EU, Nyiv, thiab CFDA.
Qhov no ua kom ntseeg tau tias qhov zoo ntawm peb cov khoom ua tau raws li txoj cai nruj tshaj plaws. Peb ua hauj lwm nrog 24 txawv teb chaws kws tshuaj thiab cov koom haum tshawb fawb kom paub tseeb tias lawv tau txais kev ruaj ntseg zoo, tus nqi ncaj ncees nrog cov nyiaj tau los meej, thiab tag nrho cov ntaub ntawv lawv xav tau kom yooj yim tshem tawm kev lis kev cai.
Peb peb -tier zoo system- Hoobkas kuaj, sab hauv QA/QC department pov thawj, thiab ntawv pov thawj los ntawm ib tug thib peb -tsoom fwv txoj cai- xyuas kom meej tias txhua batch ntawm Bioglutide NA-931 ua tau raws li qhov yuav tsum tau. Peb paub tias hnub kawg ntawm kev kawm yog qhov tseem ceeb, thiab peb lub ERP platform muab sijhawm rau koj raws sijhawm thiab kev thauj mus los thoob plaws koj lub neej kev txiav txim. Txawm hais tias koj xav tau kev tshawb fawb ntau npaum li cas rau cov kev tshawb fawb hauv tsev kho mob lossis kev tsim khoom ntau rau kev kho mob, BLOOM TECH muab cov khoom lag luam txhim khu kev qha uas txhawb nqa los ntawm kev txawj ntse thiab kev pabcuam cov neeg siv khoom.
Npaj txhij los txhim kho koj cov kev tshawb fawb kab mob metabolic nrog siab -zoo Bioglutide NA-931? Hu rau peb pab neeg hnub no ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau tshwj xeeb.
Kev siv
1. Finan, B., et al. (2013). Unimolecular dual incretins thiab glucagon receptor agonists rau kev kho mob ntawm cov kab mob metabolic. Nature Medicine, 19(11), 1407–1415.
2. Drucker, DJ (2018). Mechanisms of Action and Therapeutic Application of Glucagon-zoo li Peptide-1. Cell Metabolism, 27(4), 740–756.
3. Frias, JP, et al. (2021). Tirzepatide piv rau Semaglutide Ib zaug ib lim piam hauv cov neeg mob uas muaj ntshav qab zib hom 2. New England Journal of Medicine, 385, 503–515.
4. Jastreboff, AM, et al. (2022). Tirzepatide Ib zaug ib lub lim tiam rau kev kho mob rog. New England Journal of Medicine, 387, 205–216.
5. Holst, JJ (2007). Lub physiology ntawm glucagon-zoo li peptide 1. Physiological Reviews, 87(4), 1409–1439.
6. Clemmons, DR (2012). Lub luag haujlwm ntawm IGF-Kuv nyob rau hauv kev kho mob pob txha pob txha. Endocrine Reviews, 33(3), 448–465.